You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Secondary Progress Multiple Sclerosis

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Multiple Sclerosis Trial (Frexalimab, Placebo, MRI contrast-enhancing agents)

Not yet recruiting
  • Multiple Sclerosis
  • (no location specified)
Nov 15, 2023

Mayzent Onboarding of Secondary Progressive Multiple Sclerosis

Completed
  • Secondary Progressive Multiple Sclerosis
    • Camperdown, New South Wales, Australia
    • +1 more
    Apr 19, 2023

    Secondary Progress Multiple Sclerosis, Multiple Sclerosis Trial in San Diego (NeuroVax, IFA Placebo)

    Recruiting
    • Secondary Progress Multiple Sclerosis
    • Multiple Sclerosis
    • NeuroVax
    • IFA Placebo
    • San Diego, California
      CRO
    Mar 9, 2020

    Multiple Sclerosis (MS) Patients

    Not yet recruiting
    • Multiple Sclerosis, Relapsing-Remitting
    • +2 more
      • (no location specified)
      Dec 15, 2022

      Multiple Sclerosis, Secondary Progressive, Multiple Sclerosis Trial in Warsaw (Cladribine Subcutaneous Injection, 0.9% Chloride

      Recruiting
      • Multiple Sclerosis, Secondary Progressive
      • Multiple Sclerosis
      • Cladribine Subcutaneous Injection
      • 0.9% Chloride Injection Sodium
      • Warsaw, Mazowieckie, Poland
        Institute of Psychiatry and Neurology
      Jul 26, 2023

      Multiple Sclerosis, Multiple Sclerosis, Primary Progressive, Multiple Sclerosis, Secondary Progressive Trial in Palo Alto

      Not yet recruiting
      • Multiple Sclerosis
      • +2 more
      • KYV-101 anti-CD19 CAR-T cell therapy
      • Standard lymphodepletion regimen
      • Palo Alto, California
        Stanford Multiple Sclerosis Center
      Nov 13, 2023

      Multiple Sclerosis, Relapsing-Remitting, Multiple Sclerosis, Secondary Progressive Trial in Tokyo (OCH-NCNP1, Placebo)

      Active, not recruiting
      • Multiple Sclerosis, Relapsing-Remitting
      • Multiple Sclerosis, Secondary Progressive
      • Tokyo, Japan
        National Center of Neurology and Psychiatry
      Sep 28, 2022

      Multiple Sclerosis Trial (Siponimod)

      Available
      • Multiple Sclerosis
      • (no location specified)
      Sep 13, 2022

      Secondary-progressive Multiple Sclerosis Trial in Buffalo (Mayzent, Ocrevus)

      Recruiting
      • Secondary-progressive Multiple Sclerosis
      • Buffalo, New York
        University at Buffalo, Buffalo General Hospital
      Oct 10, 2022

      Progressive Multiple Sclerosis Trial in Lille, Strasbourg (Placebo, Masitinib (4.5))

      Recruiting
      • Progressive Multiple Sclerosis
      • Placebo
      • Masitinib (4.5)
      • Lille, France
      • +1 more
      Jul 1, 2022

      Relapsing Remitting Multiple Sclerosis, Secondary Progressive Multiple Sclerosis Trial in Birmingham, Saint Louis (Glycemic

      Not yet recruiting
      • Relapsing Remitting Multiple Sclerosis
      • Secondary Progressive Multiple Sclerosis
      • Glycemic load
      • +2 more
      • Birmingham, Alabama
      • +1 more
      Jan 4, 2023

      Multiple Sclerosis, Primary Progressive Multiple Sclerosis, Secondary-progressive Multiple Sclerosis Trial in Belgium (Metformin

      Not yet recruiting
      • Multiple Sclerosis
      • +2 more
      • Metformin Hydrochloride 850 mg Oral Tablet
      • Placebo
      • Brugge, Belgium
      • +4 more
      May 30, 2023

      Primary Progressive Multiple Sclerosis, Secondary Progressive Multiple Sclerosis, Multiple Sclerosis Trial (Intranasal Foralumab

      Withdrawn
      • Primary Progressive Multiple Sclerosis
      • +2 more
      • Intranasal Foralumab Solution
      • Placebo
      • (no location specified)
      Feb 14, 2022

      Assessment of Disease Progress in Multiple Sclerosis

      Completed
      • Multiple Sclerosis
        • Berlin, Germany
          NeuroCure Clinical Reserach Center, Charité Universitaetsmedizin
        Jul 28, 2021

        Multiple Sclerosis, Secondary Progressive Trial in Calgary (Hydroxychloroquine Pill, Indapamide Pill)

        Recruiting
        • Multiple Sclerosis, Secondary Progressive
        • Hydroxychloroquine Pill
        • Indapamide Pill
        • Calgary, Alberta, Canada
          Foothills Medical Centre
        May 16, 2022

        Secondary Progressive Multiple Sclerosis Trial in Germany (BAF312, Baseline disease modifying therapies (DMTs))

        Active, not recruiting
        • Secondary Progressive Multiple Sclerosis
        • BAF312
        • Baseline disease modifying therapies (DMTs)
        • Mittweida, Sachsen, Germany
        • +9 more
        Aug 9, 2022

        Multiple Sclerosis, Relapsing-Remitting, Adult ALL, Vitamin D3 Deficiency Trial (25(OH)D3, vitamin D3)

        Not yet recruiting
        • Multiple Sclerosis, Relapsing-Remitting
        • +2 more
        • 25(OH)D3
        • vitamin D3
        • (no location specified)
        Apr 16, 2022

        Secondary Progressive Multiple Sclerosis, Primary Progressive Multiple Sclerosis Trial in Los Angeles (Metformin 500 Mg Oral

        Recruiting
        • Secondary Progressive Multiple Sclerosis
        • Primary Progressive Multiple Sclerosis
        • Metformin 500 Mg Oral Tablet, up to 4 tablets a day
        • Placebo oral tablet identical to metformin, up to 4 tablets a day
        • Los Angeles, California
          University of California, Los Angeles
        May 2, 2022

        Multiple Sclerosis Trial in Majadahonda, Madrid (Botulinum toxin type A infiltrations)

        Completed
        • Multiple Sclerosis
        • Botulinum toxin type A infiltrations
        • Majadahonda, Madrid, Spain
        • +1 more
        Aug 8, 2022

        Multiple Sclerosis, Multiple Sclerosis, Primary Progressive, Multiple Sclerosis, Secondary Progressive Trial in San Francisco

        Recruiting
        • Multiple Sclerosis
        • +2 more
        • N-acetyl cysteine
        • Placebo
        • San Francisco, California
          University of California, San Francisco
        Mar 22, 2022

        Relapsing Multiple Sclerosis, Relapsing Remitting Multiple Sclerosis, Secondary Progressive Multiple Sclerosis Trial in United

        Recruiting
        • Relapsing Multiple Sclerosis
        • +2 more
        • Autologous Hematopoietic Stem Cell Transplantation
        • Best Available Therapy (BAT)
        • Palo Alto, California
        • +20 more
        Jan 25, 2023

        Multiple Sclerosis, Relapsing-Remitting, Multiple Sclerosis, Secondary Progressive, Multiple Sclerosis, Primary Progressive

        Completed
        • Multiple Sclerosis, Relapsing-Remitting
        • +2 more
        • 18F-DPA-714 and 18F-FDG
        • Paris, France
        • +1 more
        Sep 14, 2022

        Secondary Progressive Multiple Sclerosis (SPMS) Trial in Tel Aviv (SCM-010)

        Not yet recruiting
        • Secondary Progressive Multiple Sclerosis (SPMS)
        • SCM-010
        • Tel Aviv, Israel
          Tel Aviv Medical Center
        Oct 26, 2022

        Secondary Progressive Multiple Sclerosis, Multiple Sclerosis, Secondary Progressive, Multiple Sclerosis Trial in Salt Lake City

        Recruiting
        • Secondary Progressive Multiple Sclerosis
        • +2 more
        • Ferumoxytol infusion
        • +2 more
        • Salt Lake City, Utah
          University of Utah Health Imaging and Neurosciences Center
        Jun 22, 2022

        Multiple Sclerosis, Chronic Progressive, Multiple Sclerosis, Multiple Sclerosis, Primary Progressive Trial in Porto Alegre

        Not yet recruiting
        • Multiple Sclerosis, Chronic Progressive
        • +3 more
        • Nordic Walking (NWG)
        • +2 more
        • Porto Alegre, Rio Grande Do Sul, Brazil
          Universidade Federal do Rio Grande do Sul
        May 17, 2022